🕵️ Abbvie Inc. ($ABBV)
SEC insider & ownership activity, last 12 months · CIK 1551152 · every row links its SEC filing
Over the last 12 months insiders sold $21.8M with no open-market buying against it. Perry C Siatis sold $9.5M through a 10b5-1 trading plan in 4 lots (Feb–Mar). 1 planned sale is pending, the largest $2.8M (Robert J Alpern). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 4 sellers, $21.8M (8 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Perry C Siatis | 0 | – | 4 | $9.5M | Mar 2, 2026 |
| Saleki-Gerhardt Azita | 0 | – | 1 | $8.4M | Aug 12, 2025 |
| Nicholas Donoghoe | 0 | – | 2 | $2.6M | Aug 5, 2025 |
| David R. Purdue | 0 | – | 1 | $1.2M | Mar 4, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Vanguard Capital Management | 7.5% | 13G | Apr 29, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Robert J Alpern | $2.8M | May 26, 2026 | filing ↗ |
| David R. Purdue | $1.2M | Mar 4, 2026 | filing ↗ |
| Perry C Siatis | $4.4M | Mar 2, 2026 | filing ↗ |
| Perry C Siatis | $5.1M | Feb 25, 2026 | filing ↗ |
| Richard A. Gonzalez | $13.2M | Aug 22, 2025 | filing ↗ |
| Richard A. Gonzalez | $19.0M | Aug 21, 2025 | filing ↗ |
| Azita Saleki-Gerhardt | $8.4M | Aug 12, 2025 | filing ↗ |
| Nicholas Donoghoe | $2.6M | Aug 5, 2025 | filing ↗ |
| Richard A. Gonzalez | $6.8M | Aug 4, 2025 | filing ↗ |
| Richard A. Gonzalez | $19.2M | Aug 4, 2025 | filing ↗ |
| Richard A. Gonzalez | $12.0M | Aug 1, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | Jul 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 6, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 18, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 18, 2026 | filing ↗ |
| Shareholder vote (5.07) | May 8, 2026 | filing ↗ |
| Earnings (2.02) | Apr 29, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 29, 2026 | filing ↗ |
| Earnings (2.02) | Apr 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 3, 2026 | filing ↗ |
| Other events (8.01) | Mar 4, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 4, 2026 | filing ↗ |
| Other events (8.01) | Feb 24, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 24, 2026 | filing ↗ |
| Earnings (2.02) | Feb 4, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 4, 2026 | filing ↗ |
| Earnings (2.02) | Jan 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 7, 2026 | filing ↗ |
| Earnings (2.02) | Oct 31, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 31, 2025 | filing ↗ |
| Earnings (2.02) | Oct 3, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 3, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Sep 11, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 11, 2025 | filing ↗ |
| Earnings (2.02) | Jul 31, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 31, 2025 | filing ↗ |